David W. Anstice
Non-Executive Director
business
abott
Ireland
Biography
David W. Anstice is a retired senior executive and company director, working globally, and based in Pennsylvania, USA. Today, in addition to being a director of NeuClone, he is a non-executive director of two public companies, CSL Limited (ASX: CSL), based in Melbourne, Australia and Alkermes Plc, based in Dublin, Ireland (NASDAQ: ALKS). Mr. Anstice retired as a senior executive of Merck & Co., Inc., in September 2008, after a 35 year career. He had reported to Merck’s CEO, in various assignments, including President, The Americas; President, Asia Pacific; and President, Japan, since 1994. Prior to that date he was President of Merck’s European business. Mr. Anstice also served on the Board of Directors, and Executive Committee, of the Biotechnology Industry Organization in Washington, D.C. from 1996 to 2005.
Research Interest
microbiology
